Search clinical trials for: Metabolic dysfunction-Associated Steatohepatitis (MASH)

Total 56404 results

Novo Nordisk A/S

Completed

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey (BARRIERS-MASLD)

Non-alcoholic Steatohepatitis (MASH) | Non-alcoholic Fatty Liver Disease (MASLD)

India
Aligos Therapeutics

Recruiting

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) (HERALD)

Nonalcoholic Steatohepatitis | NASH | MASH | Metabolic Dysfunction-Associated Steatohepatitis

United States
Akero Therapeutics, Inc

Recruiting

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis | MASH With Fibrosis

United States, Canada, Puerto Rico, Australia, India, France, Italy, Poland, Spain
Akero Therapeutics, Inc

Recruiting

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NASH/MASH | NAFLD/MASLD

United States, Canada, Puerto Rico, Australia, India
University of Southern California

Active, not recruiting

Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)

Delayed Cerebral Ischemia | Vasospasm, Intracranial | Aneurysm, Ruptured | Blood Brain Barrier Defect

United States
Sheffield Teaching Hospitals NHS Foundation Trust

Active, not recruiting

Management of Acutely Symptomatic Hernia (MASH)

Emergencies | Hernia | Surgery--Complications

United Kingdom
Rush University Medical Center
Lumos Labs, Inc.

Terminated

Memory Training in Aneurysmal Subarachnoid Hemorrhage Patients (MASH)

Subarachnoid Hemorrhage | Ruptured Aneurysm | Memory Deficits

United States
DemeRx IB, Inc.
Hammersmith Medicines Research; ERT: Clinical Trial Technology Solutions; MAC...

Recruiting

A Study of Oral Ibogaine in Opioid Withdrawal

Opiate Withdrawal Syndrome

United Kingdom
Corcept Therapeutics

Recruiting

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Nonalcoholic Steatohepatitis (NASH) | Metabolic Dysfunction-associated Steatohepatitis (MASH)

United States, Puerto Rico
Grand Valley State University

Enrolling by invitation

Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults

Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD) | Metabolic Associated-dysfunction Steatohepatitis (MASH)

United States
Neuraly, Inc.

Not yet recruiting

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

NAFLD | NASH

United States
Regeneron Pharmaceuticals

Recruiting

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Non-Alcoholic Steatohepatitis (NASH) in Adult Participants at Increased Genetic Risk for This Condition (NASHGEN-2)

Non-alcoholic Steatohepatitis (NASH) | Metabolic Dysfunction Associated Steatohepatitis (MASH)

United States, Korea, Republic of, Puerto Rico, Japan
Ali Aminian

Not yet recruiting

Fibrosis Lessens After Metabolic Surgery (FLAMES)

Obesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)

United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
Rush University Medical Center

Recruiting

Testing Feasibility of Medication Adherence Problem Solving for Hypertension (MASH)

Hypertension | Adherence, Medication

United States
89bio, Inc.

Not yet recruiting

Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc.

Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis

United States
University of Pittsburgh

Completed

Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study (MASH)

Bacterial Vaginosis

United States
University of Delaware
University of Pittsburgh; Duke University; National Institute on Aging (NIA)

Completed

Manual Therapy and Strengthening for the Hip in Older Adults With Chronic Low Back Pain (MASH)

Osteoarthritis | Chronic Low-back Pain | Hip Impairments | Hip-spine Syndrome

United States
Innovation Research & Training
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Evaluation of a Middle School Comprehensive Sexual Health Media Literacy Education Program (MASH)

Safe Sex

United States
Erasmus Medical Center

Completed

Manta™ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial (MASH-TAVI)

Aortic Valve Stenosis

Netherlands
NEAT ID Foundation
PENTA Foundation; European Commission; VERDI Consortium

Recruiting

Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV (MASH 1)

Monkeypox | HIV Coinfection

Spain, France, Poland, United Kingdom
University of Bologna

Recruiting

Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis (KETONASH)

Obesity | NAFLD | Liver Fibrosis | NASH

Italy
Boehringer Ingelheim

Recruiting

A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight

Obesity | Non-Alcoholic SteatoHepatitis (NASH)

United States
AstraZeneca

Recruiting

A Trial to Learn How Safe AZD9550 is in People With Type 2 Diabetes Who Are Overweight or Obese (CONTEMPO)

Non-alcoholic Steatohepatitis (NASH)

Austria, Germany, Japan, Sweden
Pichamol Jirapinyo, MD, MPH

Not yet recruiting

ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial

Liver Diseases | Metabolic Diseases | Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Insulin Resistance | Weight Loss | Liver Fat | NAFLD | Insulin Sensitivity/Resistance | Insulin Sensitivity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non Alcoholic Fatty... and other conditions

United States
Merck Sharp & Dohme LLC

Recruiting

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

Non-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Fatty Liver, Nonalcoholic

Canada, United States, Puerto Rico, Japan, Korea, Republic of, Taiwan, Spain, Israel, Chile, France, Italy, Hungary, Switzerland, Belgium, China, Singapore, Czechia, Portugal, Austria, United Kingdom, Thailand, Hong Kong, Turkey, Colo...
Massachusetts General Hospital
GE Healthcare

Recruiting

Conditionally Increased Output (CIO) Enhanced Ultrasound System

Fatty Liver | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver

United States
Dr Adnan Agha

Recruiting

Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue

Liver Fat | Type 2 Diabetes | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

United Arab Emirates
Brigham and Women's Hospital

Recruiting

Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease

Obesity | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

United States
University Hospital, Ghent

Recruiting

Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass (LABOR)

Hypoglycemia | Gastric Outlet Obstruction | Steatohepatitis | Gastric Bypass | Parenteral Support

Belgium
Institut National de la Santé Et de la Recherche...
Centre Hospitalier Universitaire de Nice

Not yet recruiting

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome (CHALNA2)

Hepatocellular Carcinoma | Cirrhosis, Liver | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Alcohol-related Liver Disease
Instituto de Investigación Marqués de Valdecilla

Not yet recruiting

Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis (EMOTION)

Patients With Nonalcoholic Steatohepatitis
West Virginia University

Recruiting

Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

Nonalcoholic Fatty Liver Disease

United States
Franciscus Gasthuis
Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaborators

Not yet recruiting

The Franciscus Obesity NASH Study (FONS)

NAFLD | Obesity, Morbid | NASH - Nonalcoholic Steatohepatitis

Netherlands
Aristotle University Of Thessaloniki
424 General Military Hospital

Recruiting

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease (OsteoNAFLD)

Osteoporosis, Postmenopausal | Nonalcoholic Fatty Liver

Greece
Dana-Farber Cancer Institute

Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Lung Cancer | Cirrhosis | Barrett Esophagus | Hematologic Malignancy | Non-Alcoholic Fatty Liver Disease | Cancer Risk | Vulvar Intraepithelial Neoplasia | Childhood Cancer Survivors | Lung; Node | Non Alcoholic Steatohepatitis | Osteochondroma | Cancer Predisposition Syndrome | Hereditary Cancer Prediction | Adult... and other conditions

United States
University of Oklahoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Metabolic Pathology of Pediatric NAFLD

Obesity | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver

United States
University of Copenhagen
Hvidovre University Hospital

Recruiting

An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis (FALL)

Chronic Liver Disease

Denmark
Medical University of Vienna

Recruiting

Gut Permeability and Bariatric-metabolic Surgery

Bariatric Surgery Candidate | NASH - Nonalcoholic Steatohepatitis | Intestinal Permeability

Austria
Stanford University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance

Obesity | Diabetes Mellitus, Type 2 | Insulin Resistance | PreDiabetes | Diet Modification | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver

United States
LMC Diabetes & Endocrinology Ltd.

Recruiting

Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

Type 2 Diabetes | Nonalcoholic Steatohepatitis

Canada
Getz Pharma

Recruiting

Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

Diabetes Mellitus, Type 2 | NAFLD | NASH - Nonalcoholic Steatohepatitis

Pakistan
Madrigal Pharmaceuticals, Inc.

Recruiting

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Non-Alcoholic Fatty Liver Disease

United States, Puerto Rico
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis) (FRAMES)

Fibrosis | Cirrhosis | NAFLD | NASH - Nonalcoholic Steatohepatitis | NASH
Axcella Health, Inc

Recruiting

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

Non Alcoholic Steatohepatitis (NASH)

United States, Canada, United Kingdom, Australia, France, Poland, Puerto Rico
Assiut University

Not yet recruiting

Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt

Steatohepatitis, Nonalcoholic
Inventiva Pharma

Recruiting

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) (NATiV3)

NASH - Nonalcoholic Steatohepatitis

United States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...
Novo Nordisk A/S

Recruiting

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) (ESSENCE)

Non-alcoholic Steatohepatitis

United States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Switzerland, Ireland, Belgium, Romania, Ger... and more
Brigham and Women's Hospital
Boston Scientific Corporation; American Society for Gastrointestinal Endoscopy

Recruiting

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Obesity | Non-alcoholic Fatty Liver Disease (NAFLD) | Liver Function | Non-alcoholic Steatohepatitis (NASH) | Liver Fibroses | Endoscopic Ultrasound | Endoscopic Sleeve Gastroplasty

United States
Maastricht University Medical Center

Not yet recruiting

Plant Stanols and Liver Inflammation in Overweight and Obese Children

Pediatric Obesity | Childhood Obesity | NAFLD | NASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | NASH | Childhood Overweight

Netherlands

Search clinical trials for: Metabolic dysfunction-Associated Steatohepatitis (MASH)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations